{"id":"adapalene-gel","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Erythema"},{"rate":"10-25","effect":"Scaling"},{"rate":"10-20","effect":"Dryness"},{"rate":"5-15","effect":"Pruritus"},{"rate":null,"effect":"Photosensitivity"}]},"_chembl":{"chemblId":"CHEMBL1265","moleculeType":"Small molecule","molecularWeight":"412.53"},"_dailymed":{"setId":"c448eab6-c054-4c8b-9319-556b7e1be3cf","title":"ADAPALENE GEL USP, 0.3% GEL [BRYANT RANCH PREPACK]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Adapalene selectively binds to retinoic acid receptor gamma (RAR-γ) and other retinoid receptors, promoting keratinocyte differentiation and reducing sebum production. It decreases comedone formation and has anti-inflammatory properties, making it effective for treating acne by normalizing follicular epithelial desquamation and reducing bacterial colonization.","oneSentence":"Adapalene is a third-generation retinoid that binds to retinoic acid receptors to normalize skin cell differentiation and reduce inflammation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:26:34.634Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acne vulgaris"}]},"trialDetails":[{"nctId":"NCT07473895","phase":"PHASE2","title":"Topical 5% Spironolactone Gel Versus 0.1% Adapalene Gel for Acne Vulgaris: A Randomized Split-Face Study","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-04","conditions":"Acne Vulgaris","enrollment":40},{"nctId":"NCT07421804","phase":"NA","title":"Evaluation of Topical Dutasteride as a Potential New Therapy for Facial Acne Vulgaris Versus the Triple Combination Therapy (Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel)","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-04","conditions":"Acne Vulgaris","enrollment":50},{"nctId":"NCT07205107","phase":"","title":"Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris","status":"RECRUITING","sponsor":"Bausch Health Americas, Inc.","startDate":"2025-10-02","conditions":"Acne Vulgaris","enrollment":200},{"nctId":"NCT07348978","phase":"NA","title":"Auricular Acupressure Combined With Adapalene for the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"University of Medicine and Pharmacy at Ho Chi Minh City","startDate":"2024-11-01","conditions":"Acne Vulgaris","enrollment":64},{"nctId":"NCT05582434","phase":"EARLY_PHASE1","title":"Experience With Topical Acne Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2024-02-15","conditions":"Acne","enrollment":72},{"nctId":"NCT04892706","phase":"PHASE2","title":"Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2021-06-11","conditions":"Acne Vulgaris","enrollment":686},{"nctId":"NCT06336603","phase":"PHASE4","title":"A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries Limited","startDate":"2023-11-15","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT07102186","phase":"PHASE4","title":"Efficacy and Safety of Adapalene Gel and Hyaluronic Acid Versus Adapalene Gel Alone in Mild to Moderate Acne Vulgaris","status":"RECRUITING","sponsor":"Badr University","startDate":"2025-07-21","conditions":"Acne Vulgaris","enrollment":120},{"nctId":"NCT07016360","phase":"PHASE4","title":"Comparison of Effectiveness of Topical Retinoids Versus Liquid Nitrogen in Treatment of Plantar Warts(Viral Infection)","status":"RECRUITING","sponsor":"Khyber Teaching Hospital","startDate":"2025-06-15","conditions":"Viral Warts","enrollment":98},{"nctId":"NCT06673641","phase":"PHASE1","title":"A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2024-05-13","conditions":"Acne Vulgaris","enrollment":382},{"nctId":"NCT06451237","phase":"PHASE3","title":"Acne Remission Maintenance by Weekend Systemic Isotretinoin","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2018-01-20","conditions":"Acne Vulgaris","enrollment":60},{"nctId":"NCT00422240","phase":"PHASE3","title":"Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2006-06-27","conditions":"Acne Vulgaris","enrollment":1668},{"nctId":"NCT05536882","phase":"PHASE3","title":"MC RCT - BPO vs Adapalene","status":"WITHDRAWN","sponsor":"University of Oklahoma","startDate":"2022-05-18","conditions":"Molluscum Contagiosum","enrollment":""},{"nctId":"NCT00446043","phase":"PHASE3","title":"Long-term Study of Efficacy/Safety of Adapalene/Benzoyl Peroxide Topical Gel in Acne Vulgaris Subjects","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2004-02-17","conditions":"Acne Vulgaris","enrollment":452},{"nctId":"NCT03076320","phase":"PHASE1, PHASE2","title":"Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne","status":"COMPLETED","sponsor":"University of Guadalajara","startDate":"2017-03-27","conditions":"Acne Vulgaris Superficial Mixed Comedonal and Inflammatory","enrollment":82},{"nctId":"NCT05899699","phase":"PHASE2","title":"Effect of New Topical Preparation for Treatment of Acne Vulgaris","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2023-06-05","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT05855629","phase":"NA","title":"\"A Comparative Clinical Evaluation of the Efficacy of Topical Adapalene, Benzoyl Peroxide Gel, Oral Lactobacillus Rhamnosus, D-chiro-inositol, Inulin Capsule, and Their Fixed Combination in Mild to Moderate Acne Vulgaris Patients.\"","status":"UNKNOWN","sponsor":"Treatment and Diagnostic Center of Private Enterprise \"Asklepiy\"","startDate":"2022-02-18","conditions":"Acne Vulgaris","enrollment":59},{"nctId":"NCT04823845","phase":"EARLY_PHASE1","title":"Plantar Wart Treatment Using Adapalene Gel","status":"WITHDRAWN","sponsor":"University of Louisville","startDate":"2022-05-01","conditions":"Plantar Wart","enrollment":""},{"nctId":"NCT02899000","phase":"PHASE4","title":"A Treatment for Severe Inflammatory Acne Subjects","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2016-07-29","conditions":"Acne Vulgaris","enrollment":186},{"nctId":"NCT02735421","phase":"PHASE4","title":"Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2016-05-13","conditions":"Acne Vulgaris, Atrophic Acne Scars","enrollment":67},{"nctId":"NCT02249104","phase":"PHASE4","title":"A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2014-08","conditions":"Acne Vulgaris","enrollment":28},{"nctId":"NCT00671749","phase":"PHASE4","title":"Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2007-12","conditions":"Acne Vulgaris","enrollment":100},{"nctId":"NCT01951417","phase":"PHASE4","title":"Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2013-10","conditions":"Acne","enrollment":81},{"nctId":"NCT00647556","phase":"PHASE3","title":"Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2008-04","conditions":"Photoaging","enrollment":30},{"nctId":"NCT01209949","phase":"PHASE4","title":"Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2010-10","conditions":"Acne Vulgaris","enrollment":30},{"nctId":"NCT00907101","phase":"PHASE4","title":"Evaluate Effectiveness of Epiduo® Gel in Reducing Antibiotic Sensitive & Resistant Strains of Propionibacterium (P)Acnes","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2009-06","conditions":"P Acnes Colonization","enrollment":30},{"nctId":"NCT01522456","phase":"PHASE4","title":"Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin Gel","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2012-04","conditions":"Acne Vulgaris","enrollment":73},{"nctId":"NCT00469755","phase":"PHASE4","title":"Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2006-02","conditions":"Acne Vulgaris","enrollment":302},{"nctId":"NCT00437151","phase":"PHASE4","title":"Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1%","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2006-06","conditions":"Acne","enrollment":61},{"nctId":"NCT05096312","phase":"PHASE4","title":"Effects of Oral Zinc Gluconate Among Acne Vulgaris Patients","status":"COMPLETED","sponsor":"East Avenue Medical Center, Philippines","startDate":"2018-12-21","conditions":"Acne Vulgaris","enrollment":23},{"nctId":"NCT03573115","phase":"NA","title":"Multimodal Optical Imaging for Pretreatment Evaluation for Cutaneous Microparticle Delivery","status":"COMPLETED","sponsor":"Merete Haedersdal","startDate":"2018-01-04","conditions":"Acne Vulgaris, Microparticles","enrollment":16},{"nctId":"NCT03393494","phase":"PHASE3","title":"Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2017-12-13","conditions":"Acne Vulgaris","enrollment":825},{"nctId":"NCT02525549","phase":"PHASE3","title":"Comparative Safety and Bioequivalence of Two Treatments in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2011-12","conditions":"Acne","enrollment":903},{"nctId":"NCT03832647","phase":"PHASE4","title":"Anti-acne Efficacy of a Dermo-cosmetic Product Associated With the Fixed Combination Adapalene 0.1%/ Benzoyl Peroxide 2.5% Treatment Versus This Treatment Associated With a Standard Moisturizer in Male and Female Subjects Presenting With Mild to Moderate Acne","status":"COMPLETED","sponsor":"Vichy Laboratoires","startDate":"2019-02-18","conditions":"Acne","enrollment":200},{"nctId":"NCT03563365","phase":"PHASE4","title":"The Functional and Emotional Benefits of Replenix Power of Three With Resveratrol","status":"TERMINATED","sponsor":"Yardley Dermatology Associates","startDate":"2018-06-04","conditions":"Acne Vulgaris","enrollment":43},{"nctId":"NCT04797793","phase":"EARLY_PHASE1","title":"A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2020-05-18","conditions":"Acne Vulgaris","enrollment":978},{"nctId":"NCT00660985","phase":"PHASE4","title":"Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1%","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2008-05","conditions":"Acne Vulgaris","enrollment":51},{"nctId":"NCT00421993","phase":"PHASE3","title":"A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2006-10","conditions":"Acne Vulgaris","enrollment":1670},{"nctId":"NCT00687908","phase":"PHASE3","title":"Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2008-11","conditions":"Acne","enrollment":243},{"nctId":"NCT01138735","phase":"PHASE4","title":"Epiduo Pediatric Acne Study","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2010-06","conditions":"Acne","enrollment":285},{"nctId":"NCT01188538","phase":"PHASE4","title":"Anti Propionibacterium(P.) Acnes Activity of Epiduo® Gel Compared to Benzoyl Peroxide (BPO) 2.5% Gel","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2010-03","conditions":"Acne Vulgaris","enrollment":40},{"nctId":"NCT01106807","phase":"PHASE2","title":"Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2010-04","conditions":"Acne","enrollment":73},{"nctId":"NCT00688064","phase":"PHASE3","title":"Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2008-08","conditions":"Severe Acne Vulgaris","enrollment":459},{"nctId":"NCT01213199","phase":"PHASE2","title":"Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2011-03","conditions":"Acne Scars","enrollment":20},{"nctId":"NCT01014689","phase":"PHASE3","title":"Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2009-08","conditions":"Acne Vulgaris","enrollment":378},{"nctId":"NCT01474590","phase":"PHASE3","title":"Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2011-11","conditions":"Acne","enrollment":266},{"nctId":"NCT00883233","phase":"PHASE3","title":"Comparison of Four Different Regimens of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2009-04","conditions":"Acne","enrollment":123},{"nctId":"NCT02932267","phase":"PHASE3","title":"Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2017-02-02","conditions":"Acne Vulgaris","enrollment":50},{"nctId":"NCT00971282","phase":"PHASE4","title":"Adjunctive Usage of a Moisturizing Lotion (Cetaphil® Moisturizing Lotion) to Limit the Skin Irritation Linked to the Set-Up of a Treatment by Topical Retinoid (Differin® Gel 0,1%) in Healthy Subjects of Chinese Origins","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2008-12","conditions":"Healthy Skin","enrollment":30},{"nctId":"NCT00441415","phase":"PHASE3","title":"Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2007-02","conditions":"Acne Vulgaris","enrollment":272},{"nctId":"NCT04329403","phase":"PHASE3","title":"Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1%","status":"WITHDRAWN","sponsor":"Aurobindo Pharma Ltd","startDate":"2020-07","conditions":"Acne Vulgaris","enrollment":""},{"nctId":"NCT02651220","phase":"PHASE3","title":"Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Actavis Inc.","startDate":"2015-11","conditions":"Acne","enrollment":1001},{"nctId":"NCT03650881","phase":"NA","title":"The Comparative Efficacy of an Over the Counter Light Therapy Mask vs Over the Counter Topical Benzoyl Peroxide 2.5% and Used in Combination With Over the Counter Adapalene Gel 0.1% for Mild to Moderate Acne","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"2018-08-07","conditions":"Acne","enrollment":""},{"nctId":"NCT03615768","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2018-08-14","conditions":"Acne Vulgaris","enrollment":1617},{"nctId":"NCT02593383","phase":"PHASE1, PHASE2","title":"Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2015-03-01","conditions":"Acne","enrollment":245},{"nctId":"NCT03650361","phase":"PHASE3","title":"Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris","status":"COMPLETED","sponsor":"Aleor Dermaceuticals Limited","startDate":"2018-09-17","conditions":"Acne Vulgaris","enrollment":755},{"nctId":"NCT03457636","phase":"PHASE4","title":"The Use of Oracea and Epiduo Forte in Severe Acne Patients","status":"COMPLETED","sponsor":"Derm Research, PLLC","startDate":"2018-03-19","conditions":"Acne","enrollment":22},{"nctId":"NCT01504204","phase":"PHASE4","title":"Effect of Samples on Acne Treatment With Epiduo® Gel","status":"COMPLETED","sponsor":"Wake Forest University","startDate":"2011-12","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT00696449","phase":"PHASE4","title":"Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris","status":"COMPLETED","sponsor":"Wake Forest University","startDate":"2006-06","conditions":"Acne Vulgaris","enrollment":61},{"nctId":"NCT00658112","phase":"PHASE4","title":"Measuring Adherence in Subjects With Acne Vulgaris in a Clinic Population Subtitle: Topical Benzoyl Peroxide for Acne","status":"COMPLETED","sponsor":"Wake Forest University","startDate":"2006-07","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT02557399","phase":"PHASE4","title":"DUAC® Early Onset Efficacy Study in Japanese Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-10-07","conditions":"Acne Vulgaris","enrollment":350},{"nctId":"NCT03585140","phase":"NA","title":"Low Glycemic Index and Load Diet for the Treatment of Acne","status":"COMPLETED","sponsor":"Centro Dermatológico Dr. Ladislao de la Pascua","startDate":"2016-01-01","conditions":"Acne Vulgaris, Diet Modification","enrollment":52},{"nctId":"NCT00757523","phase":"PHASE4","title":"Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2008-09-10","conditions":"Acne Vulgaris","enrollment":382},{"nctId":"NCT00160394","phase":"PHASE4","title":"Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2004-12","conditions":"Acne Vulgaris","enrollment":130},{"nctId":"NCT02411942","phase":"PHASE1","title":"Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2014-08","conditions":"Acne Vulgaris","enrollment":753},{"nctId":"NCT02709902","phase":"PHASE1","title":"Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2015-09","conditions":"Acne Vulgaris","enrollment":460},{"nctId":"NCT01742637","phase":"PHASE1","title":"Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2012-10","conditions":"Acne Vulgaris","enrollment":2008},{"nctId":"NCT01406080","phase":"PHASE3","title":"A Comparative Study of Adapalene Gel,0.3% Versus Tretinoin Emollient Cream, 0.05% for the Treatment of Photoaging","status":"COMPLETED","sponsor":"Galderma Brasil Ltda.","startDate":"2013-01","conditions":"Photoaging, Photodamage","enrollment":128},{"nctId":"NCT01910064","phase":"PHASE3","title":"A Long Term Study of GK530G in Subjects With Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2013-05","conditions":"Acne Vulgaris","enrollment":436},{"nctId":"NCT02073448","phase":"PHASE3","title":"Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris.","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2014-03","conditions":"Acne Vulgaris","enrollment":417},{"nctId":"NCT02716090","phase":"PHASE3","title":"Clinical Trial Phase III to Assess the Non-inferiority of Dalap Duo® Product Compared to Epiduo® in the Treatment of Acne Vulgaris","status":"WITHDRAWN","sponsor":"Ache Laboratorios Farmaceuticos S.A.","startDate":"","conditions":"Acne Vulgaris","enrollment":""},{"nctId":"NCT02173054","phase":"PHASE3","title":"An Efficiency of a Moisturizer Containing Licochalcone A, L-carnitine and 1,2-decanediol With Adapalene Gel in Acne","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2014-07","conditions":"Acne","enrollment":120},{"nctId":"NCT02721173","phase":"PHASE4","title":"Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris","status":"COMPLETED","sponsor":"All India Institute of Medical Sciences, Bhubaneswar","startDate":"2016-04","conditions":"Acne Vulgaris","enrollment":60},{"nctId":"NCT00887484","phase":"PHASE4","title":"A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-02","conditions":"Acne Vulgaris","enrollment":50},{"nctId":"NCT00964223","phase":"PHASE4","title":"A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-07","conditions":"Acne Vulgaris","enrollment":28},{"nctId":"NCT02338544","phase":"","title":"Application of Epiduo(R) PUMP in Daily Practice in Patients With Inflammatory Acne","status":"COMPLETED","sponsor":"Galderma Laboratorium GmbH","startDate":"2015-01","conditions":"Acne Vulgaris","enrollment":1388},{"nctId":"NCT00926367","phase":"PHASE4","title":"Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-05","conditions":"Acne Vulgaris","enrollment":52},{"nctId":"NCT01387048","phase":"PHASE4","title":"Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin","status":"COMPLETED","sponsor":"University of Magdeburg","startDate":"2011-08","conditions":"Acne Vulgaris","enrollment":60},{"nctId":"NCT01425320","phase":"PHASE1","title":"Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne","status":"WITHDRAWN","sponsor":"Allergan","startDate":"2013-01","conditions":"Acne Vulgaris","enrollment":""},{"nctId":"NCT00829049","phase":"PHASE4","title":"Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris","status":"TERMINATED","sponsor":"Allergan","startDate":"2007-10","conditions":"Acne Vulgaris","enrollment":165},{"nctId":"NCT01231334","phase":"PHASE4","title":"A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne","status":"COMPLETED","sponsor":"Allergan","startDate":"2010-08","conditions":"Acne Vulgaris","enrollment":286},{"nctId":"NCT01485367","phase":"PHASE2","title":"A Pilot Study to Evaluate The Efficacy of Adapalene 0.3% for Use in the Prevention and Treatment of Senile Purpura","status":"UNKNOWN","sponsor":"Multispecialty Aesthetic Clinical Research Organization","startDate":"2011-12","conditions":"Senile Purpura","enrollment":20},{"nctId":"NCT00807014","phase":"PHASE4","title":"Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2006-11","conditions":"Acne Vulgaris","enrollment":169},{"nctId":"NCT01149330","phase":"PHASE4","title":"Evaluation of Efficacy and Safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma Brasil Ltda.","startDate":"2010-07","conditions":"Acne Vulgaris","enrollment":75},{"nctId":"NCT00919191","phase":"PHASE4","title":"Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2009-04","conditions":"Acne Vulgaris","enrollment":26},{"nctId":"NCT00952523","phase":"PHASE4","title":"Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2009-07","conditions":"Acne Vulgaris","enrollment":162},{"nctId":"NCT00714714","phase":"PHASE4","title":"Evaluation of Irritation That Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face.","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2008-01","conditions":"Acne Vulgaris","enrollment":25},{"nctId":"NCT01501799","phase":"NA","title":"A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris","status":"COMPLETED","sponsor":"Actavis Mid-Atlantic LLC","startDate":"2011-07","conditions":"Acne Vulgaris","enrollment":885},{"nctId":"NCT00719121","phase":"PHASE1","title":"Study on Anti-inflammatory Effects of Topical R115866 Gel","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2006-11","conditions":"Cutaneous Inflammation","enrollment":12},{"nctId":"NCT01245946","phase":"PHASE2","title":"Photodynamic Therapy Compared to Adapalene 0.1% Gel Plus Doxycycline in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2010-10","conditions":"Acne","enrollment":46},{"nctId":"NCT00151541","phase":"PHASE3","title":"A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4%","status":"COMPLETED","sponsor":"Allergan","startDate":"2005-02","conditions":"Acne Vulgaris","enrollment":301},{"nctId":"NCT01182636","phase":"PHASE1","title":"Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2007-07","conditions":"Acne Vulgaris","enrollment":601},{"nctId":"NCT01095640","phase":"NA","title":"Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel","status":"COMPLETED","sponsor":"Actavis Mid-Atlantic LLC","startDate":"2009-03","conditions":"Acne Vulgaris","enrollment":1159},{"nctId":"NCT00237978","phase":"PHASE4","title":"Control of Therapy of Acne Papulopustulosa by Visible Light With Waterfiltered Infrared and / or Adapalen (Differin Gel)","status":"UNKNOWN","sponsor":"Technische Universität Dresden","startDate":"2006-09","conditions":"Acne Papulopustulosa","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[{"date":"20260310","type":"SUPPL","sponsor":"P AND L","applicationNumber":"ANDA090962"},{"date":"20100602","type":"ORIG","sponsor":"P AND L","applicationNumber":"ANDA090962"},{"date":"20190708","type":"SUPPL","sponsor":"P AND L","applicationNumber":"ANDA090962"},{"date":"20120614","type":"ORIG","sponsor":"ENCUBE ETHICALS","applicationNumber":"ANDA200298"},{"date":"20190709","type":"SUPPL","sponsor":"GLENMARK PHARMS INC","applicationNumber":"ANDA091314"},{"date":"20100701","type":"ORIG","sponsor":"GLENMARK PHARMS INC","applicationNumber":"ANDA091314"}],"publicationCount":128,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Differin Gel .3%","Differin"],"phase":"marketed","status":"active","brandName":"Adapalene Gel","genericName":"Adapalene Gel","companyName":"Bausch Health Americas, Inc.","companyId":"bausch-health-americas-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Adapalene gel is a small molecule that acts as a retinoic acid receptor agonist. It is used to treat acne and acne vulgaris, as indicated by clinical trials.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1996-05-31T00:00:00.000Z","mah":"GALDERMA LABS LP","brand_name_local":"DIFFERIN","application_number":"NDA020338"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1996-05-31T00:00:00.000Z","mah":"GALDERMA LABS LP","brand_name_local":"DIFFERIN","application_number":"NDA020380"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2000-05-26T00:00:00.000Z","mah":"GALDERMA LABS LP","brand_name_local":"DIFFERIN","application_number":"NDA020748"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2007-06-19T00:00:00.000Z","mah":"GALDERMA LABS LP","brand_name_local":"DIFFERIN","application_number":"NDA021753"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2010-03-17T00:00:00.000Z","mah":"GALDERMA LABS LP","brand_name_local":"DIFFERIN","application_number":"NDA022502"},{"country_code":"US","regulator":"FDA","status":"supplemented","approval_date":"2010-06-02T00:00:00.000Z","mah":"P AND L","brand_name_local":null,"application_number":"ANDA090962"},{"country_code":"US","regulator":"FDA","status":"supplemented","approval_date":"2010-07-01T00:00:00.000Z","mah":"GLENMARK PHARMS INC","brand_name_local":null,"application_number":"ANDA091314"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2012-06-14T00:00:00.000Z","mah":"ENCUBE ETHICALS","brand_name_local":null,"application_number":"ANDA200298"}],"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}